Tablet test vs paper test for thinking in cirrhosis
Part of Brain & nervous system, Digestive system, Hormones & metabolism clinical trials.
This study compares two ways of testing thinking and memory in people with liver cirrhosis. It aims to see if a tablet-based test is as good as the standard paper version for detecting early signs of confusion (hepatic encephalopathy).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have a confirmed diagnosis of liver cirrhosis.
- You must be able to think clearly and have no current confusion or disorientation caused by liver disease.
- You must be willing to participate and follow the study procedures.
- You must not have taken sedatives, sleeping pills, or psychiatric medications in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with liver cirrhosis to learn more about a condition called hepatic encephalopathy, which can cause confusion and memory problems. It aims to improve how doctors find and treat this condition.
This study compares using an electronic version of a short thinking test with a traditional paper test to diagnose hepatic encephalopathy, a brain condition caused by liver disease. It aims to make diagnosis easier and more accurate for patients with cirrhosis.
This study uses a set of paper-and-pencil thinking tests (called PHES) to detect a mild form of brain fog that can occur with cirrhosis, known as minimal hepatic encephalopathy. The goal is to help doctors identify this early so it can be managed before it becomes more serious.
This study is creating a new test to measure thinking and memory problems in people with liver cirrhosis. It may help doctors find these problems earlier.
This study looks at how well simple brain tests can detect early (minimal) thinking changes related to liver cirrhosis. It may help doctors spot these changes sooner and diagnose the condition more accurately.
This study tests whether melatonin (a natural sleep hormone) can improve sleep and thinking abilities in people with cirrhosis and liver-related brain fog. It aims to see if better sleep leads to clearer thinking.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.